Robert Ramer
Impact in
- Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
- Inflammatory mediators and NSAID effects
Papers in
- Pharmacology 38
- Cannabis and Cannabinoid Research 34
- Inflammatory mediators and NSAID effects 6
-
- Glaucoma and retinal disorders 4
- Co-authors
- Burkhard Hinz (49 shared papers)Jutta Merkord (8 shared papers)Kay Brune (9 shared papers)Michael Linnebacher (7 shared papers)Maria Haustein (4 shared papers)Achim Salamon (3 shared papers)Katrin Manda (2 shared papers)Igor Ivanov (3 shared papers)
- Journals
- Biochemical Pharmacology (5 papers)Cells (4 papers)Oncotarget (4 papers)Pharmaceutical Research (3 papers)Biochemical and Biophysical Research Communications (3 papers)
- Partner nations
- Germany
In The Last Decade
Robert Ramer
55 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 87
- Pharmacology 1.6k
- Drug Discovery 4
- Cancer Research 136
- Ophthalmology 91
- Sensory Systems 38
Countries citing papers authored by Robert Ramer
This map shows the geographic impact of Robert Ramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Ramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Ramer more than expected).
Fields of papers citing papers by Robert Ramer
This network shows the impact of papers produced by Robert Ramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Ramer. The network helps show where Robert Ramer may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Ramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 192 | |
| 2 | 2007 | 189 | |
| 3 | 2009 | 157 | |
| 4 | 2011 | 151 | |
| 5 | 2018 | 119 | |
| 6 | 2022 | 99 | |
| 7 | 2004 | 88 | |
| 8 | 2014 | 86 | |
| 9 | 2010 | 83 | |
| 10 | 2013 | 70 | |
| 11 | 2014 | 65 | |
| 12 | 2009 | 63 | |
| 13 | 2017 | 62 | |
| 14 | 2019 | 62 | |
| 15 | 2016 | 58 | |
| 16 | 2003 | 55 | |
| 17 | 2005 | 50 | |
| 18 | 2018 | 45 | |
| 19 | 2008 | 44 | |
| 20 | 2016 | 44 |
About Robert Ramer
Robert Ramer is a scholar working on Pharmacology, Ophthalmology, Cancer Research, Molecular Biology and Toxicology, having authored 55 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (34 papers), Inflammatory mediators and NSAID effects (6 papers), Angiogenesis and VEGF in Cancer (5 papers), Glaucoma and retinal disorders (4 papers), Synthesis and biological activity (3 papers), Protease and Inhibitor Mechanisms (2 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Mesenchymal stem cell research (2 papers). The work is most often cited by research in Pharmacology (1.6k citations), Drug Discovery (4 citations), Cancer Research (136 citations), Ophthalmology (91 citations) and Sensory Systems (38 citations). Robert Ramer has collaborated with scholars based in Germany. Frequent co-authors include Burkhard Hinz, Jutta Merkord, Kay Brune, Michael Linnebacher, Maria Haustein, Achim Salamon, Katrin Manda, Igor Ivanov, Kirsten Peters and Udo Ingbert Walther. Their work appears in journals such as Biochemical Pharmacology, Cells, Oncotarget, Pharmaceutical Research and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.